Basic Information
Basic information for LINC02235-213-65aa
Peptide Name LINC02235-213-65aa
Genome Position chr8:81842619-81842671,81873402-81873518,81874267-81874291[+]
Species Human
Peptide Sequence MGARPPEERLELIGWALSFTLVAQAGVQWCDFSLLKPPPPRFKRFSCLSFPSSWNYSVAGEKNLG
Peptide Length 65
Unique Yes
Grand Average of Hydropathicity -0.1123
Relative Molecular Mass 8438.34
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000254689;LINC02235
Transcript ID/Name ENST00000671467;LINC02235-213
Transcript Length 688
Coding Ability 0.8576
DNA Sequence Corresponding to Peptide ATGGGCGCCCGCCCACCGGAGGAGCGACTGGAGTTGATCGGCTGGGCGCTCAGTTTCACTCTTGTTGCCCAGGCTGGAGTGCAATGGTGTGATTTCAGCTTACTGAAACCTCCACCTCCTAGGTTCAAGAGATTCTCCTGCCTCAGCTTCCCGAGTAGCTGGAATTACAGTGTGGCTGGTGAGAAGAACTTGGGA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :